Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × fosaprepitant × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2 Genitourinary 2 Thoracic 1 Sarcoma 1 Head & Neck 1 Dermatologic 1 Breast 1

Conditions

Vomiting 1 Sarcoma 1 Neoplasms 1 Nausea 1

Interventions

dexamethasone acetate 2 Vincristine 2 Mesna 2 Ifosfamide 2 Doxorubicin 2 Dexamethasone 2 Calcium Dobesilate 2 fosaprepitant 1 Palonosetron 1 Ondansetron 1 Octreotide 1 Electroacupuncture 1 Dexrazoxane 1 Cyproheptadine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed

47 enrolled 6 charts

Nausea, Neoplasms, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡